US › Healthcare

Bionano Genomics Inc (BNGO)

US · Healthcare · Medical Instruments & Supplies

$1.74+15.23%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$8.2M

Revenue YoY

+21.4%

Net profit

$-7.4M

EPS

$-0.64

EPS estimate

$-0.70

Net margin

-90.8%

EPS came in at -0.64 against a street estimate of -0.70 — a beat of 8.6%.

Key statistics

Market cap

$18.4M

Forward P/E

0.0

P/B

0.50

Book value

$2.68

EPS (TTM)

$-3.53

52-week high

$2.23

52-week low

$1.00

50-day MA

$1.17

200-day MA

$1.27

Beta

1.65

Analyst view

Analysts rate Bionano Genomics Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $5.00.

Shareholding

Insiders

7.22%

Institutions

8.49%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.42%
GSA Capital Partners LLP	1.28%
Carret & Company Inc	1.06%
Vanguard Capital Management, LLC	0.58%
Vanguard Fiduciary Trust Co	0.44%
Renaissance Technologies Corp	0.41%
Prudential Financial Inc	0.27%
Northern Trust Corp	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bionano Genomics Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.